Psilocybin-assisted Psychotherapy for Clinicians

Therapist talking to a clinician sitting in a chair

Dec 6, 2024 - In clinicians experiencing depression or burnout after providing Covid-19 care in 2020 and 2021, psilocybin-assisted psychotherapy resulted in significant reductions in depression. The findings offer evidence that guided psilocybin therapy is “dramatically different” than conventional psychotherapy, said Dr. Anthony Back, the trial's lead investigator. In a study of front-line providers, the psychedelic drug reduced symptoms of depression more effectively than a placebo. Findings from this double-blind, randomized clinical trial were published today in JAMA Network Open.